Natera

Director, Revenue Cycle Billing Strategy

United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Revenue Cycle ManagementIndustries

Position Overview

  • Location Type: Not specified
  • Employment Type: Not specified
  • Salary: Not specified
  • Job Type: Director
  • Brief Description: The Director of Billing Strategy will lead strategic improvements within Natera’s revenue cycle processes, overseeing product reimbursement and revenue cycle operations to impact financial performance. This role will work across departments to integrate RCM knowledge with process improvements, data analysis, and strategic initiatives.

Primary Responsibilities

  • Manages revenue cycle projects related to specific products by identifying opportunities for process improvement.
  • Redesign processes and documentation of SOPs, implementation of new workflows, and monitoring of operational metrics.
  • Serves as a source of subject matter expertise and performs analysis, identifies trends, presents solutions and insights, and prioritizes initiatives for process and performance improvement.
  • Responsible for developing appropriate workflows and tracking all aspects related to the lifecycle of a claim by performing routine assessment of SOP compliance, audits of claims, and in-depth analysis of trends in denials, claims management, etc.
  • Establishes an ongoing working relationship with other departments that impact revenue cycle performance.
  • Works closely with various RCM vendors and teams (Eligibility, Prior Authorization, Claims Management, AR/Denial Management, and Patient Billing) to oversee operational activity that directly impacts the revenue cycle.
  • Accurately process actions in a timely manner for optimal reimbursement.
  • Track outcomes of payment resolution, appeals, and negotiated claims to ensure goals are met.
  • Collect data metrics on revenue cycle tools and develop processes focused on these tools, including but not limited to: consents, protocols, SOPs.
  • Create systems, patient and payer materials related to revenue cycle management.

Qualifications

  • 7-10 years of revenue cycle experience, relevant work experience, and/or a Master’s degree in Healthcare Administration or Analytics.
  • Experience working in biotech or laboratory billing is strongly preferred.
  • Extensive knowledge of government and commercial insurance reimbursement policies, prior authorizations, and eligibility requirements.
  • Extensive knowledge of reimbursement, billing, coding, and compliance regulations is required.

Additional Information

  • This role works with PHI on a regular basis both in paper and electronic form and will have access to various technologies that provide access to PHI (paper and electronic) in order to perform the job.
  • Employee must complete training relating to HIPAA/PHI privacy, General Policies and Procedure Compliance training, and security training as soon as possible but not later than the first 30 days of hire.
  • Must maintain a current status on Natera training requirements.
  • Performs other duties as assigned.

Skills

Revenue Cycle
Process Improvement
Data Analysis
Workflow Design
SOP Development
Claims Management
Denial Management
Reimbursement
Patient Billing
Payer Relations
Consent Management
Protocols

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI